Menu
Home
Publishers
Categories
Trending
Inbox
Create Account
Sign in
Nederlands
Deutsch
Loading...
Fiercebiotech.com
Click on 'Go to the website!' to go to Fiercebiotech.com.
Button get active in
5
Continue to the website!
Loading...
Loading...
Other newsletters from Fiercebiotech.com
Don't be the only one at Your Company who misses this webinar - Register now
Fiercebiotech.com
1752335317
| 07.12.25 | Trump signs 'big, beautiful bill'; Judge hits CVS' Omnicare with $949M in penalties
Fiercebiotech.com
1752323568
| 07.11.25 | FDA document drop sheds light on drug refusal process; Agency rejects Capricor DMD cell therapy
Fiercebiotech.com
1752255796
Why top gene therapy manufacturers are rethinking lysis
Fiercebiotech.com
1752254803
| 07.11.25 | FDA rebuffs Capricor’s DMD cell thera py; Karyopharm shrinks workforce as pressure mounts
Fiercebiotech.com
1752250330
| 07.11.25 | Biopharma layoffs jump 32% in first half of 2025; Trump renews 200% tariff threat on drugs
Fiercebiotech.com
1752239503
Biologics Are Booming—Is Your Delivery Strategy Keeping Up?
Fiercebiotech.com
1752175175
| 07.10.25 | FDA publishes 200 drug rejection letters; After 16 years, Jazz has a new CEO
Fiercebiotech.com
1752174532
The Chemistry Breakthrough You've Been Waiting For
Fiercebiotech.com
1752170981
| 07.10.25 | FDA shares 200-plus drug rejection letters; AbbVie pays $700M for J&J, Pfizer blood cancer rival
Fiercebiotech.com
1752163866
Key Factors That Impact CDMO Success in Rare Disease Programs
Fiercebiotech.com
1752089102
| 07.09.25 | Merck makes $10B respiratory M&A p lay for Verona; AZ’s Alexion pens $825M AAV pact
Fiercebiotech.com
1752088137
| 07.09.25 | AZ’s Alexion inks $825M AAV pact ; Rhythm obesity pill hits high note in ph. 2
Fiercebiotech.com
1752078573
| 07.08.25 | H1 biopharma layoffs up 32% YOY; Novartis' malaria drug for infants wins world-first approval
Fiercebiotech.com
1752004205
Fix The #1 Cause of Specialty Rx Abandonment
Fiercebiotech.com
1751995229
| 07.08.25 | Taiho’s DMD asset misses mark in ph. 3; Concentra buys struggling CAR-T biotech
Fiercebiotech.com
1751993644
| 07.07.25 | CSL to trim R&D staff in hunt for more external team-ups; Baxter taps new CEO
Fiercebiotech.com
1751915305
| 07.07.25 | Roche’s Chugai pens $250M Gero deal for ag e-related diseases; Jasper's dud drug batch sinks stock
Fiercebiotech.com
1751903244
Don't be the only one at Your Company to miss this webinar!
Fiercebiotech.com
1751899806
ML Is Giving Drug Developers an Edge—Are You In?
Fiercebiotech.com
1751893973
© 2025
Information
Terms and Conditions
Privacy
Close
Home
Publishers
Categories
Trending
Inbox
Create Account
Sign in
© 2025
Information
Terms and Conditions
Privacy
Nederlands
Deutsch